These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9849719)

  • 21. Prognostic implications of histological tumor regression (Böhm's score) in patients receiving neoadjuvant chemotherapy for high grade serous tubal & ovarian carcinoma.
    Rajkumar S; Polson A; Nath R; Lane G; Sayasneh A; Jakes A; Begum S; Mehra G
    Gynecol Oncol; 2018 Nov; 151(2):264-268. PubMed ID: 30197060
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adenocarcinoma of the fallopian tube: report of a case with an unusual pattern of metastasis and response to combination chemotherapy.
    Young JA; Kossman CR; Green MR
    Gynecol Oncol; 1984 Feb; 17(2):238-40. PubMed ID: 6546733
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Operation--chemotherapy and radiotherapy of adenocarcinoma of the fallopian tube].
    Pakisch B; Poschauko J; Kettenbach H; Stücklschweiger G; Poier E; Lahousen M; Pickel H; Klug P; Hackl A
    Gynakol Rundsch; 1990; 30 Suppl 1():215-6. PubMed ID: 2079276
    [No Abstract]   [Full Text] [Related]  

  • 24. Poor performance status (PS) is an indication for an aggressive approach to neoadjuvant chemotherapy in patients with advanced epithelial ovarian cancer (EOC).
    Seifert H; Georgiou A; Alexander H; McLachlan J; Bodla S; Kaye S; Barton D; Nobbenhuis M; Gore M; Banerjee S
    Gynecol Oncol; 2015 Nov; 139(2):216-20. PubMed ID: 26318078
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serous fallopian tube carcinoma: a retrospective, multi-institutional case-control comparison to serous adenocarcinoma of the ovary.
    Moore KN; Moxley KM; Fader AN; Axtell AE; Rocconi RP; Abaid LN; Cass IA; Rose PG; Leath CA; Rutledge T; Blankenship D; Gold MA
    Gynecol Oncol; 2007 Dec; 107(3):398-403. PubMed ID: 17997146
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term survival of a patient with fallopian tube cancer presenting with a supraclavicular mass.
    Scholz HS; Lax S; Tamussino KF; Benedicic C; Petru E
    Anticancer Res; 2000; 20(6C):4801-2. PubMed ID: 11205221
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemotherapy consisting of paclitaxel and carboplatin benefits a patient with malignant mixed müllerian tumor of the fallopian tube.
    Kawaguchi W; Itamochi H; Kigawa J; Kanamori Y; Oishi T; Shimada M; Sato S; Sato S; Terakawa N
    Int J Clin Oncol; 2008 Oct; 13(5):461-3. PubMed ID: 18946759
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Primary metastasizing fallopian tube carcinoma. Case report and overview of current therapy].
    Behr J; Thyselius D; Jäger W; Paterok EM
    Zentralbl Gynakol; 1990; 112(23):1477-80. PubMed ID: 2291372
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stage III malignant mixed Müllerian tumor of the fallopian tube: a case of 5-year survival after optimal debulking and adjuvant chemotherapy with paclitaxel plus carboplatin.
    Tsai CP; Ho ES; Ke YM; Hsu ST; Wang RC; Lu CH
    Taiwan J Obstet Gynecol; 2012 Jun; 51(2):294-6. PubMed ID: 22795114
    [No Abstract]   [Full Text] [Related]  

  • 30. Primary fallopian tube carcinoma.
    Pardeshi SP; Kulkarni MM; Hishikar VA
    J Postgrad Med; 1996; 42(2):59-61. PubMed ID: 9715305
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of early-stage primary serous fallopian tube carcinomas and equivalent stage serous epithelial ovarian carcinomas.
    Horng HC; Lai CR; Chang WH; Wen KC; Chen YJ; Juang CM; Yen MS; Wang PH
    Taiwan J Obstet Gynecol; 2014 Dec; 53(4):547-51. PubMed ID: 25510699
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Population-based study of survival for women with serous cancer of the ovary, fallopian tube, peritoneum or undesignated origin - on behalf of the Swedish gynecological cancer group (SweGCG).
    Dahm-Kähler P; Borgfeldt C; Holmberg E; Staf C; Falconer H; Bjurberg M; Kjölhede P; Rosenberg P; Stålberg K; Högberg T; Åvall-Lundqvist E
    Gynecol Oncol; 2017 Jan; 144(1):167-173. PubMed ID: 27817932
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recurrent metastatic fallopian tube carcinoma in pregnancy.
    Adolph A; Le T; Khan K; Biem S
    Gynecol Oncol; 2001 Apr; 81(1):110-2. PubMed ID: 11277660
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of treatment failures and survival of patients with fallopian tube carcinoma: a cooperation task force (CTF) study.
    Gadducci A; Landoni F; Sartori E; Maggino T; Zola P; Gabriele A; Rossi R; Cosio S; Fanucchi A; Tisi G
    Gynecol Oncol; 2001 May; 81(2):150-9. PubMed ID: 11330942
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Primary carcinoma of the fallopian tube.
    Kadziora MB; Srinivasan R
    Can J Surg; 1981 Jul; 24(4):425-6. PubMed ID: 6791798
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Primary carcinoma of the fallopian tube.
    Podratz KC; Podczaski ES; Gaffey TA; O'Brien PC; Schray MF; Malkasian GD
    Am J Obstet Gynecol; 1986 Jun; 154(6):1319-26. PubMed ID: 3013008
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Salvage chemotherapy in recurrent platinum-resistant or refractory epithelial ovarian cancer with Carboplatin and distearoylphosphatidylcholine pegylated liposomal Doxorubicin (lipo-dox®).
    Khemapech N; Oranratanaphan S; Termrungruanglert W; Lertkhachonsuk R; Vasurattana A
    Asian Pac J Cancer Prev; 2013; 14(3):2131-5. PubMed ID: 23679331
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endometrioid carcinoma of the oviduct.
    Seraj IM; Chase DR; King A
    Gynecol Oncol; 1991 May; 41(2):152-5. PubMed ID: 2050305
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low drug resistance to both platinum and taxane chemotherapy on an in vitro drug resistance assay predicts improved survival in patients with advanced epithelial ovarian, fallopian and peritoneal cancer.
    Matsuo K; Bond VK; Eno ML; Im DD; Rosenshein NB
    Int J Cancer; 2009 Dec; 125(11):2721-7. PubMed ID: 19530239
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Malignant mixed müllerian tumor of the fallopian tube.
    Zorlu CG; Cobanoglu O; Kuşçu E; Aribas D
    Acta Obstet Gynecol Scand; 1994 Apr; 73(4):352-4. PubMed ID: 8160547
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.